Vatsala S. Sastry, MD
NPI 1336131481ActiveIndividual· Internal Medicine, Infectious Disease· Brooksville, FL
Listed on the HHS-OIG exclusion list since October 2026 (1128b4). Internal Medicine, Infectious Disease (MD) in Brooksville, Florida, licensed in FL, with an NPI issued in August 2005. In 2024 Medicare paid $963,141 for 173 patients, and Part D covered 886 of their prescriptions, 70% of them generic. Gilead Sciences, Inc. was the largest of 6 companies reporting payments in 2025, $524.56 in all, mostly food and beverage.
Overview
| NPI | 1336131481 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Aug 16, 2005 |
| Last updated in NPPES | Dec 19, 2011 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Infectious Disease Primary | 207RI0200X | ME68115 | FL |
Exclusion screening
This NPI appears on the OIG exclusion list. Excluded parties cannot be paid by Medicare, Medicaid or other federal health care programs, directly or through an employer.
| Matched by | Name on OIG list | Exclusion type | Excluded since | Location |
|---|---|---|---|---|
| NPI | Vatsala Sitarama Sastry · Internal Medicine | 1128b4 | Oct 20, 2026 | Dade City, FL |
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | Listed (NPI) | See above |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Infectious Disease (FL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 173 |
|---|---|
| Services billed | 996,503 across 22 procedure codes |
| Paid by Medicare | $963,141 |
Part D prescriptions in 2024
| Prescriptions (claims) | 886 · 897 30-day fills |
|---|---|
| Patients | 172 |
| Total drug cost | $1,132,174 |
| Generic share | 70% of claims |
Education and affiliations
| Graduation year | 1985 |
|---|---|
| Medicare specialty | Infectious Disease |
Industry payments (Open Payments)
- 2025$524.56 · 31 payments from 6 companies
- 2024$21,713 · 45 payments from 7 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Gilead Sciences, Inc. | $169.55 | 14 |
| Cumberland Pharmaceuticals, Inc. | $102.04 | 4 |
| Paratek Pharmaceuticals, Inc. | $100.44 | 6 |
| Insmed, Inc. | $66.61 | 3 |
| Viiv Healthcare Company | $43.05 | 2 |
What the 2025 payments were for
- Food and Beverage$524.56 · 31 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other infectious disease specialists in Brooksville
- 1558718999
- 1811183908
- 1700773694
- 1891745683